Board of Astrazeneca Pharma India recommends final dividend

Astrazeneca Pharma India announced that the Board of Directors of the Company at its meeting held on 30 May 2025, inter alia, have recommended the final dividend of Rs 32 per equity Share (i.e. 1600%) , subject to the approval of the shareholders.